Pre-Settlement Funding & Lawsuit Loans: The Real Cost (2026)

An injured person with no income and mounting bills is the most financially pressured party in the entire claims process — and the industry that has grown up around that pressure is regulated unevenly, with the protections you get depending heavily on which state you are in.

Pre-settlement funding is not inherently predatory, and for some people it prevents an eviction. But it is expensive in a way that the marketing does not make obvious, and the cost compounds while a case takes its natural course.

Quick answer: Advances are commonly quoted at 2%–5% per month — roughly 27% to over 80% a year where the rate compounds. In the only large-scale independent study, funders’ realised return averaged about 44% a year after defaults and write-offs. A two-year compounding advance can more than double what you owe. Ask for the total repayment at 6, 12, 18 and 24 months in writing before signing, and exhaust the cheaper options first.

How It Works

1. You apply, usually through a funding company that contacts claimants directly or through your law firm.
2. The company evaluates the case, not your credit — liability strength, injury severity, the defendant’s insurance.
3. They advance a percentage of expected recovery, commonly 10%–20%.
4. Repayment comes out of the settlement at disbursement, ahead of you.
5. It is generally non-recourse: no recovery, no repayment obligation.

That non-recourse structure is the whole legal argument. Because repayment is contingent, funding companies maintain the product is not a loan — which is what keeps most of them outside state usury caps and consumer lending disclosure rules. A number of states have enacted specific disclosure requirements or rate limits for litigation funding, so the position varies by where you are.

What It Actually Costs

The rate is quoted monthly, and whether it compounds is the single most important term in the agreement — ask explicitly, because both structures are sold. As a rough pattern, compounding is offered at a lower monthly rate on stronger cases, and simple interest at a higher monthly rate on weaker ones, sometimes with a hard multiplier cap (often 2×) that limits the total. A simple-interest deal with a cap behaves very differently from the table below.

On a $10,000 advance, compounding:

Case duration	At 2%/mo compounded	At 3%/mo compounded	At 4%/mo compounded
6 months	~$11,260	~$11,940	~$12,650
12 months	~$12,680	~$14,260	~$16,010
18 months	~$14,280	~$17,020	~$20,260
24 months	~$16,080	~$20,330	~$25,630

Figures are illustrative compound calculations on the stated monthly rate, before any origination or administrative fees, which are common and add to the total.

At 4% monthly over two years, a $10,000 advance costs more than $15,000 in fees. And injury claims routinely take one to two years — see our guide to how long settlements take.

The stacking problem

The advance is not the only claim on the proceeds. At disbursement the money is applied roughly in this order:

1. Attorney fees
2. Case costs
3. Medical liens and subrogation claims
4. The funding company’s repayment
5. You

A $60,000 settlement with a 33% fee, $3,000 in costs, $12,000 in negotiated liens and a $20,000 funding balance leaves roughly $5,200. Claimants are frequently shocked at this point, and by then nothing can be undone.

The Indirect Cost: Pressure on Your Own Case

This matters as much as the arithmetic. Insurers succeed with low early offers because waiting is expensive for injured people. A large and growing funding balance makes waiting more expensive — which pushes toward accepting less.

The mechanism is worth stating plainly: the product sold to relieve financial pressure can increase the pressure that reduces your recovery. Where a case would benefit from being filed and litigated, a claimant watching a compounding balance may not be able to afford that path.

Cheaper Options, Roughly In Order

1. Ask your attorney to advance case costs. Most contingency firms already do. Costs advanced by the firm typically carry no interest, unlike a funding advance.

2. Treat on a lien or letter of protection. Many providers will treat now and be paid from the settlement. This defers medical cost without a compounding fee, and those liens are usually negotiable at the end. Our guide to getting treatment with no health insurance covers this route in full, including the catch that providers treating on a lien commonly bill full undiscounted rates.

3. Use the coverage you already have. Medical payments coverage or PIP pays regardless of fault. Health insurance pays now and asserts a lien later — a lien that can typically be reduced. See our guide to UM/UIM and first-party coverage.

4. Apply for disability benefits. Short-term disability through an employer, state disability programs where they exist, or Social Security disability for longer-term inability to work.

5. Negotiate directly with creditors. Hospitals have financial assistance and charity care policies, often unadvertised. Utilities and lenders have hardship programs. Ask.

6. A conventional loan or credit union line, if you qualify. Even a high-rate personal loan is usually cheaper than a compounding funding advance — and a credit union hardship loan much cheaper.

7. Only then, funding — and take the smallest amount that solves the immediate problem. Not the maximum offered.

What Your State Actually Regulates

The old shorthand that this industry is unregulated is no longer accurate, and the change is recent enough that most articles have not caught up. Roughly 19 states now have consumer legal funding statutes, and the two largest markets came online in 2026:

• New York’s Consumer Litigation Funding Act was signed in December 2025, with its substantive provisions effective 17 June 2026. It caps the funder’s recovery at 25% of the gross recovery.
• California’s AB 931 took effect 1 January 2026.
• Kansas’s Transparency in Consumer Legal Funding Act took effect 1 July 2026.

Where rate caps exist they vary widely — Indiana caps at 36% a year, Illinois at 18% per six months of the funded amount, and Tennessee at a 10% annual fee on the original amount. Others, including Oklahoma, impose no rate cap at all. Earlier statutes exist in Maine, Ohio, Nebraska, Vermont, Utah, Nevada, Missouri and several more.

Two cautions when reading about this elsewhere. First, a separate wave of litigation-funding transparency laws (Georgia, Montana, Louisiana, and a pending federal bill) targets commercial and mass-tort funding, not consumer advances — the two are frequently merged into one misleading count. Second, your protections depend entirely on your own state, so a national summary tells you little about your agreement.

Is it even a loan?

Funders characterise these as non-recourse purchases of part of your future recovery rather than loans, which is how they sit outside usury caps. That characterisation has been tested and, in at least one state, rejected: in Oasis Legal Finance Group, LLC v. Coffman, 2015 CO 63, 361 P.3d 400, the Colorado Supreme Court held these advances are loans subject to the state’s Uniform Consumer Credit Code despite being non-recourse. Two funders subsequently paid $2.3 million to settle with the Colorado Attorney General. Most states have not so held, so this remains Colorado law rather than a national rule.

The non-recourse feature does appear genuine in the ordinary case: if you lose, you owe nothing, and the independent research on funder returns shows they really do absorb those losses. That is precisely why the pricing is what it is.

If You Do Take an Advance

Get all of this in writing before signing:

• The total repayment amount at 6, 12, 18 and 24 months. If a company will not put this in a simple table, that itself is information.
• Whether the rate compounds, and how often.
• Every fee — origination, administrative, processing, monthly service.
• Whether there is a cap on total repayment. Some agreements have one; it materially changes the risk.
• What happens if the case takes longer than projected.
• Whether the advance is truly non-recourse, and in what circumstances you could owe money despite losing.
• Whether your attorney has reviewed it. A firm that declines to review a funding agreement is worth asking about.

And at settlement: have your attorney negotiate the balance, alongside the medical liens. Funding companies do accept reductions, particularly where full repayment would leave the claimant with nothing and where the alternative is a fight. Paying the stated balance without asking is leaving money behind.

Sources & Further Reading

• GAO-23-105210, Third-Party Litigation Financing: Market Characteristics, Data, and Trends (US Government Accountability Office, December 2022) — the neutral government overview of the market
• Avraham & Sebok, “An Empirical Investigation of Third Party Consumer Litigant Funding,” 104 Cornell Law Review 1133 (2019) — the only large-scale empirical study of actual pricing, covering more than 100,000 funding requests over twelve years, and the source of the ~44% realised annual return figure
• Oasis Legal Finance Group, LLC v. Coffman, 2015 CO 63, 361 P.3d 400 (Colo. 2015) — holding non-recourse litigation advances are loans under the Colorado UCCC
• CFPB v. RD Legal Funding, LLC (S.D.N.Y., filed February 2017, with the New York Attorney General) — alleging advances against NFL concussion and 9/11 Victim Compensation Fund settlements were usurious loans
• State consumer legal funding statutes — e.g. Ind. Code art. 24-12, 815 ILCS 121, Nev. Rev. Stat. ch. 604C, Mo. Rev. Stat. §§ 436.550–572, and New York’s Consumer Litigation Funding Act
• On the attorney’s side there is no ABA formal ethics opinion on litigation funding, contrary to what is sometimes claimed. The relevant guidance is ABA Resolution 111A, Best Practices for Third-Party Litigation Funding (August 2020) and the 2012 Ethics 20/20 white paper, alongside Model Rules 1.2(a), 1.6, 1.8(e) and 5.4(c) — the last being the bar on any third party directing your lawyer’s professional judgement.